UPDATE: Puma Biotech (PBYI) Sees Heavy Selling Pressure; SABCS Abstracts Released

November 14, 2016 10:40 AM EST

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
(Updated - November 14, 2016 10:55 AM EST)

Puma Biotech (NYSE: PBYI) is under heavy pressure. Shares down 17.7%

UPDATE: Downdside could be coming as SABCS abstracts were released. Link

There is also talk amongst traders about a PR Friday discussing a shareholder investigation. Shares last traded down 35% before being halted on a circuit breaker.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk

Add Your Comment